These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1649874)

  • 1. Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Wright PF; King J; Araki K; Kondo Y; Thompson J; Tollefson SJ; Kobayashi M; Kapikian AZ
    J Infect Dis; 1991 Aug; 164(2):271-6. PubMed ID: 1649874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Kobayashi M; Araki K; Thompson J; Tollefson SJ; Wright PF
    J Infect Dis; 1993 Mar; 167(3):748-52. PubMed ID: 8382725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
    Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
    Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
    Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
    Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
    Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
    J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children.
    Halsey NA; Anderson EL; Sears SD; Steinhoff M; Wilson M; Belshe RB; Midthun K; Kapikian AZ; Chanock RM; Samorodin R
    J Infect Dis; 1988 Dec; 158(6):1261-7. PubMed ID: 2848902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetravalent rhesus rotavirus vaccine in young infants.
    Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
    J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
    Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
    J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y; Saif LJ; Sereno MM; Chanock RM; Kapikian AZ
    J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
    Midthun K; Halsey NA; Jett-Goheen M; Clements ML; Steinhoff M; King JC; Karron R; Wilson M; Burns B; Perkis V
    J Infect Dis; 1991 Oct; 164(4):792-6. PubMed ID: 1654365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
    Vesikari T; Kapikian AZ; Delem A; Zissis G
    J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.
    Offit PA; Clark HF; Blavat G; Greenberg HB
    J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
    Green KY; Taniguchi K; Mackow ER; Kapikian AZ
    J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccines: an overview.
    Midthun K; Kapikian AZ
    Clin Microbiol Rev; 1996 Jul; 9(3):423-34. PubMed ID: 8809469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.